Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.

According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...